Brief: Kala Pharmaceuticals Received Bid Price Requirement Deficiency Letter From Nasdaq
27/05/2022 22:09
May 27 (Reuters) - Kala Pharmaceuticals Inc KALA.O :
* KALA PHARMACEUTICALS INC - ON MAY 24, RECEIVED BID PRICE
REQUIREMENT DEFICIENCY LETTER FROM NASDAQ
Further company coverage: KALA.O
((Reuters.Briefs@thomsonreuters.com;))